TransMedics Group
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. TransMedics Group's past years’ income statements indicate that its last revenue has increased compared to the previous period by 159% to $241,623,000. The net income raised on -$25,028,000 and profit margin reached -10%. Total operating expenses were $182,820,000.

Profit Margin

TransMedics Group, Inc. (NASDAQ:TMDX): Profit margin
2016 6.20M -24.06M -387.58%
2017 7.68M -20.82M -270.96%
2018 13.01M -23.75M -182.5%
2019 23.60M -33.54M -142.12%
2020 25.63M -28.74M -112.13%
2021 30.26M -44.21M -146.11%
2022 93.45M -36.23M -38.77%
2023 241.62M -25.02M -10.36%

TMDX Income Statement (2016 – 2023)

2023 2022 2021 2020 2019 2018 2017 2016
Revenue
Revenue
241.62M93.45M30.26M25.63M23.60M13.01M7.68M6.20M
Cost of revenue
87.53M28.18M9.10M9.00M9.74M7.28M5.54M5.44M
Gross profit
154.09M65.27M21.15M16.63M13.86M5.73M2.13M766K
Operating exp.
Research and development
36.05M26.81M22.30M18.83M19.87M13.65M14.95M15.63M
Selling and marketing
018.20M8.60M931K2.07M1.02M674K0
Total operating expenses
182.82M96.70M60.58M43.01M43.46M25.97M22.56M23.75M
Operating income
-28.72M-31.43M-39.42M-26.38M-29.60M-20.23M-20.42M-22.98M
Other income (expenses), net
2.05M-4.72M-4.75M-2.33M-3.90M-758K-365K-100K
Income before tax
-26.67M-36.16M-44.17M-28.71M-33.50M-23.71M-20.79M-24.06M
Income tax expense
-1.64M66K36K32K40K41K32K984K
Net income
-25.02M-36.23M-44.21M-28.74M-33.54M-23.75M-20.82M-24.06M
Earnings per share
Basic EPS
-0.77-1.23-1.6-1.16-2.36-1.23-1.44-1.66
Diluted EPS
-0.77-1.23-1.6-1.16-2.36-1.23-1.44-1.66
Data sourceData sourceData sourceData sourceData source